Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts
Class II · Moderate risk Terminated Initiated May 15, 2013 (13 years ago)

HEALTH & BEYOND DR. LARRY'S Tranquility DIETARY SUPPLEMENT 30…

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Marketed Without an Approved NDA/ANDA; product found to contain Doxepin (an antidepressant) and Chlorpromazine (an antipsychotic)

Cause type: Unapproved drug

The product was marketed without an approved NDA/ANDA, or does not meet the OTC monograph it claims to follow. Nothing about the product - dose, purity, safety - has been reviewed by FDA, so the claims on the box are unverified. All unapproved drug recalls.

What was recalled

HEALTH & BEYOND DR. LARRY'S Tranquility DIETARY SUPPLEMENT 30 Capsules Manufactured for: Health & Beyond 7050 W Palmetto Pk Rd Boca Raton, FL 33433.

Recalling firm
Health & Beyond
Origin
FL, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-1067-2014 · FDA notice

Check, then ask. Class II means harm is possible but usually temporary or reversible. Find the lot number on your package; if it matches, ask your pharmacist about a replacement. Do not simply stop a prescribed medication on your own - the gap can be riskier than the recall. This recall is now terminated, which means the firm has finished removing the affected product; anything on pharmacy shelves today should be unaffected.

Other unapproved drug recalls from 2013

All unapproved drug recalls
Class II · Moderate risk

HydrOXYzine HCI Tablets USP 50 mg

Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.

Terminated Unapproved drug KVK-Tech, Inc. D-1032-2014
Class II · Moderate risk

HydrOXYzine HCI Tablets USP 25 mg

Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.

Terminated Unapproved drug KVK-Tech, Inc. D-1031-2014
Class II · Moderate risk

HydrOXYzine HCI Tablets USP 10 mg

Good Manufacturing Practices Deviations: The product has an Active Pharmaceutical Ingredient from an unapproved source.

Terminated Unapproved drug KVK-Tech, Inc. NDC 10702-010-01 D-1030-2014
Class I · High risk

Virilis Pro

Marketed without an Approved NDA/ANDA: Dietary supplement may contain amounts of active ingredients found in some FDA-approved drugs for erectile dysfunction (ED) making the dietary supplement an unapproved drug.

Terminated Unapproved drug Haute Health, LLC D-1237-2014